NTIC vs REGN · rev $84.2M vs P/E 14, rev $14.34B
Northern Technologies (NTIC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Northern Technologies (NTIC) is a specialty chemicals company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NTIC revenue for 2025-08-31 was $84.2M. Net income was $986.4K. Revenue was down 1.0% from 2024-08-31 to 2025-08-31. NTIC currently screens at market cap $74.8M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NTIC currently screens at market cap $74.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NTIC and REGN stock pages for the full models.
Not investment advice.